Tsinghua AIR-incubated AI4S startup 'Aifei Zhiyao' secures hundred-million-yuan angel round | 36Kr First
Bubble signal: +1 · Overheating evidenceRelevance 55FundingChina
Source: 36Kr · Published 2026-09-03
Summary
Aifei Zhiyao, an AI-native drug discovery company incubated by Tsinghua University's AIR, has completed a hundred-million-yuan angel round led by Xianghe Capital. Funds will support R&D of drug foundation models and AI agent engines, and advance its own pipeline. The company uses a co-development model and has partnered with several pharma firms.
Bubble analysis
This is just an early-stage funding round for a single startup; the amount is notable but it's an isolated case and doesn't directly indicate the overall AI bubble. However, continued large investments in AI drug discovery show capital still flowing into AI applications, potentially inflating valuations.
#china#funding#startup#ai-drug-discovery
Read original ↗Related signals
linked by shared tags
- Bringing the Real World into 3D: This Company Raises Hundreds of Millions in Funding | 36Kr First Release#china#funding#startup
- Hard Kr First | 1999-born Tongji Associate Professor and former DJI core member starts world model venture, raises tens of millions in funding within a month of founding#china#funding#startup
- Two funding rounds in 4 months: Zhang Weijie aims to send computing power to the sky#china#funding
- Tsinghua PhD Secures Nine Rounds of Funding for Embodied Brain, Says No 'ChatGPT Moment' in Robotics | Hardcore Interview#china#funding
- Chinese Tech Giants Race to Monetize AI Office Agents After Free-Usage Era#china